Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases

被引:74
作者
Lee, JeHoon [1 ]
Banu, Sakhila K. [1 ]
Subbarao, Thenmozhi [1 ]
Starzinski-Powitz, Anna [2 ]
Arosh, Joe A. [1 ]
机构
[1] Texas A&M Univ, Dept Integrat Biosci, Coll Vet Med & Biomed Sci, Reprod Endocrinol & Cell Signaling Lab, College Stn, TX 77843 USA
[2] Goethe Univ Frankfurt, Inst Zellbiol & Neurowissensch, D-60323 Frankfurt, Germany
关键词
PGE(2); EP2 and EP4; Invasion; MMPs; Endometriosis; Human; TYPE-1; MATRIX-METALLOPROTEINASE; ENDOTHELIAL GROWTH-FACTOR; EUTOPIC ENDOMETRIUM; TISSUE INHIBITOR; PERITONEAL-FLUID; GENE-EXPRESSION; PROSTANOID RECEPTORS; MMP-2; ACTIVATION; DOWN-REGULATION; E-CADHERIN;
D O I
10.1016/j.mce.2010.11.022
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Prostaglandin E2 (PGE2) plays an important role in the pathogenesis of endometriosis. We recently reported that inhibition of COX-2 decreased migration as well as invasion of human endometriotic epithelial and stromal cells. Results of the present study indicates that selective inhibition of PGE2 receptors EP2 and EP4 suppresses expression and/or activity of MMP1, MMP2, MMP3, MMP7 and MMP9 proteins and increases expression of TIMP1, TIMP2, TIMP3, and TIMP4 proteins and thereby decreases migration and invasion of human immortalized endometriotic epithelial and stromal cells into matrigel. The interactions between EP2/EP4 and MMPs are mediated through Src and beta-arrestin 1 protein complex involving MT1-MMP and EMMPRIN in human endometriotic cells. These novel findings provide an important molecular and cellular framework for further evaluation of selective inhibition of EP2 and EP4 as potential nonsteroidal therapy for endometriosis in childbearing-age women. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:306 / 313
页数:8
相关论文
共 50 条
[41]   E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2 [J].
Okano, Mitsuhiro ;
Sugata, Yuji ;
Fujiwara, Tazuko ;
Matsumoto, Rie ;
Nishibori, Masahiro ;
Shimizu, Kenji ;
Maeda, Megumi ;
Kimura, Yoshinobu ;
Kariya, Shin ;
Hattori, Hisashi ;
Yokoyama, Minehiko ;
Kino, Kosuke ;
Nishizaki, Kazunori .
IMMUNOLOGY, 2006, 118 (03) :343-352
[42]   Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors [J].
Corminboeuf, Olivier ;
Diethelm, Stefan ;
Zumbrunn, Cornelia ;
Lyothier, Isabelle ;
Niggli, Nadja ;
Gnerre, Carmela ;
Jeay, Sebastien ;
Lehembre, Francois ;
Boss, Christoph .
CHEMMEDCHEM, 2024, 19 (02)
[43]   The Prostaglandin E2 Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation [J].
Philipose, Sonia ;
Konya, Viktoria ;
Sreckovic, Ivana ;
Marsche, Gunther ;
Lippe, Irmgard T. ;
Peskar, Bernhard A. ;
Heinemann, Akos ;
Schuligoi, Rufina .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (12) :2416-U165
[44]   Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists [J].
Xiao, Yufang ;
Araldi, Gian Luca ;
Zhao, Zhong ;
Brugger, Nadia ;
Karra, Srinivasa ;
Fischer, David ;
Palmer, Elizabeth .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (15) :4323-4327
[45]   Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation [J].
Kay, LJ ;
Yeo, WW ;
Peachell, PT .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 (07) :707-713
[46]   Prostaglandin E2 receptor EP2 mediates Snail expression in hepatocellular carcinoma cells [J].
Cheng, Shan-Yu ;
Zhang, Hai ;
Zhang, Min ;
Xia, Shu-Kai ;
Bai, Xiao-Ming ;
Zhang, Li ;
Ma, Juan ;
Rong, Rong ;
Wang, Yi-Pin ;
Du, Ming-Zhan ;
Wang, Jie ;
Chen, Meng ;
Shi, Feng ;
Yang, Qin-Yi ;
Leng, Jing .
ONCOLOGY REPORTS, 2014, 31 (05) :2099-2106
[47]   Prostaglandin E2 increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP4 receptors [J].
Pelletier, S ;
Dubé, J ;
Villeneuve, A ;
Gobeil, F ;
Yang, Q ;
Battistini, B ;
Guillemette, G ;
Sirois, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (05) :999-1008
[48]   Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells [J].
Hsu, Hsi-Hsien ;
Lin, Yueh-Min ;
Shen, Chia-Yao ;
Shibu, Marthandam Asokan ;
Li, Shin-Yi ;
Chang, Sheng-Huang ;
Lin, Chien-Chung ;
Chen, Ray-Jade ;
Viswanadha, Vijaya Padma ;
Shih, Hui-Nung ;
Huang, Chih-Yang .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (06)
[49]   Prostaglandin E2 Promotes Wound-Induced Migration of Intestinal Subepithelial Myofibroblasts via EP2, EP3, and EP4 Prostanoid Receptor Activation [J].
Iwanaga, Koichi ;
Okada, Muneyoshi ;
Murata, Takahisa ;
Hori, Masatoshi ;
Ozaki, Hiroshi .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (03) :604-611
[50]   Involvement of postsynaptic EP4 and presynaptic EP3 receptors in actions of prostaglandin E2 in rat supraoptic neurones [J].
Shibuya, I ;
Setiadji, SV ;
Ibrahim, N ;
Harayama, N ;
Maruyama, T ;
Ueta, Y ;
Yamashita, H .
JOURNAL OF NEUROENDOCRINOLOGY, 2002, 14 (01) :64-72